BriaCell-logo.png
BriaCell Therapeutics Corp.’s CEO Talks Personalized Breast Cancer Treatment Technology with Uptick Newswire’s Stock Day Podcast
06. November 2018 10:53 ET | BriaCell Therapeutics Corp.
PHOENIX, Nov. 06, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell,” the “Company”) (TSX-V: BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary...